| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT01739855 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | Austria | Q40 |
| P582 | end time | 2014-07-01 | |
| P4135 | maximum age | 65 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 160 | |
| P4844 | research intervention | calcium carbonate | Q23767 |
| (5R)-24,25-Dihydroxyvitamin D | Q27161510 | ||
| calcium oxalate | Q412399 | ||
| P6153 | research site | University of Vienna | Q165980 |
| P1813 | short name | BABS | |
| P580 | start time | 2012-11-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase 2 Study of Patients Undergoing Bariatric Surgery (Laparoscopic Gastric Bypass) and Evaluation of Bone Metabolism With/Without Vitamin D/Calcium Supplementation |